Indeed, it is likely that elevated REDD1 in ccRCC could limit full mTORC1 activation but not potent enough to prevent HIF2α-dependent mTORC1 activated pathways. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.